Walleye Capital’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $238K | Buy |
2,283
+697
| +44% | +$72.8K | ﹤0.01% | 1319 |
|
|
2025
Q1 | $185K | Sell |
1,586
-377
| -19% | -$44K | ﹤0.01% | 1426 |
|
|
2024
Q4 | $166K | Sell |
1,963
-44,775
| -96% | -$3.79M | ﹤0.01% | 1566 |
|
|
2024
Q3 | $4.2M | Sell |
46,738
-29,285
| -39% | -$2.63M | 0.01% | 493 |
|
|
2024
Q2 | $6.12M | Sell |
76,023
-21,097
| -22% | -$1.7M | 0.01% | 417 |
|
|
2024
Q1 | $7.75M | Buy |
+97,120
| New | +$7.75M | 0.01% | 320 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2197 |
|
|
2023
Q3 | – | Sell |
-86,280
| Closed | -$6.2M | – | 2282 |
|
|
2023
Q2 | $6.2M | Buy |
+86,280
| New | +$6.2M | 0.02% | 247 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2139 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2142 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2280 |
|
|
2022
Q2 | – | Sell |
-8,295
| Closed | -$343K | – | 2299 |
|
|
2022
Q1 | $343K | Buy |
+8,295
| New | +$343K | 0.01% | 1188 |
|
|
2020
Q1 | – | Sell |
-170,268
| Closed | -$17.6M | – | 546 |
|
|
2019
Q4 | $17.6M | Buy |
+170,268
| New | +$17.6M | 1.14% | 1 |
|
|
2018
Q3 | $62K | Buy |
+17,838
| New | +$62K | 0.03% | 254 |
|